These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 568264

  • 1. [Histochemical study of lipid metabolism of the lungs in experimental tuberculosis and its treatment].
    Bagirova IB.
    Probl Tuberk; 1978 Sep; (9):78-81. PubMed ID: 568264
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of tuberculosis infection and tuberculostatic preparations on nicotinic acid metabolism in experimental studies].
    Arkhipova OP.
    Probl Tuberk; 1974 Sep; 65(4):77-81. PubMed ID: 4835662
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Change in nucleic acid metabolism in patients with active pulmonary tuberculosis undergoing antibacterial treatment].
    Beloblotskiĭ GA.
    Vrach Delo; 1974 Jan; (1):106-7. PubMed ID: 4468551
    [No Abstract] [Full Text] [Related]

  • 9. [Use of thiamine chloride in antibacterial therapy].
    Vel'tman RP, Pugachev VS.
    Probl Tuberk; 1966 Jan; 44(12):57-61. PubMed ID: 6003079
    [No Abstract] [Full Text] [Related]

  • 10. [Nicotinic acid metabolism in patients with pulmonary tuberculosis before therapy and during antibacterial therapy].
    Belozorov PT, Vil'nianskiĭ LI, Miroshnikova VI.
    Probl Tuberk; 1967 Jan; 45(4):55-9. PubMed ID: 5606806
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chierakul N, Klomsawat D, Chulavatnatol S, Chindavijak B.
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Design and study of new agents having antitubercular activity: the original compound perchlosone as a potent agent of etiotropic therapy for tuberculosis].
    Vinogradova TI, Aleksandrova AE, Antonenkova EV, Elokhina VN, Nakhmanovich AS.
    Probl Tuberk; 1999 Mar; (3):45-7. PubMed ID: 10420769
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.